Literature DB >> 22965873

Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation.

Benedikt Gröschl1, Marcus Bettstetter, Christian Giedl, Matthias Woenckhaus, Tina Edmonston, Ferdinand Hofstädter, Wolfgang Dietmaier.   

Abstract

DUSP4 (MKP-2), a member of the mitogen-activated protein kinase phosphatase (MKP) family and potential tumor suppressor, negatively regulates the MAPKs (mitogen-activated protein kinases) ERK, p38 and JNK. MAPKs play a crucial role in cancer development and progression. Previously, using microarray analyses we found a conspicuously frequent overexpression of DUSP4 in colorectal cancer (CRC) with high frequent microsatellite instability (MSI-H) compared to microsatellite stable (MSS) CRC. Here we studied DUSP4 expression on mRNA level in 38 CRC (19 MSI-H and 19 MSS) compared to matched normal tissue as well as in CRC cell lines by RT-qPCR. DUSP4 was overexpressed in all 19 MSI-H tumors and in 14 MSS tumors. Median expression levels in MSI-H tumors were significantly higher than in MSS-tumors (p < 0.001). Consistently, MSI-H CRC cell lines showed 6.8-fold higher DUSP4 mRNA levels than MSS cell lines. DUSP4 expression was not regulated by promoter methylation since no methylation was found by quantitative methylation analysis of DUSP4 promoter in CRC cell lines neither in tumor samples. Furthermore, no DUSP4 mutation was found on genomic DNA level in four CRC cell lines. DUSP4 overexpression in CRC cell lines through DUSP4 transfection caused upregulated expression of MAPK targets CDC25A, CCND1, EGR1, FOS, MYC and CDKN1A in HCT116 as well as downregulation of mismatch repair gene MSH2 in SW480. Furthermore, DUSP4 overexpression led to increased proliferation in CRC cell lines. Our findings suggest that DUSP4 acts as an important regulator of cell growth within the MAPK pathway and causes enhanced cell growth in MSI-H CRC.
Copyright © 2012 UICC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22965873     DOI: 10.1002/ijc.27834

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  27 in total

1.  Pseudophosphatase STYX modulates cell-fate decisions and cell migration by spatiotemporal regulation of ERK1/2.

Authors:  Veronika Reiterer; Dirk Fey; Walter Kolch; Boris N Kholodenko; Hesso Farhan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-11       Impact factor: 11.205

2.  Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer.

Authors:  Susumu Saigusa; Yasuhiro Inoue; Koji Tanaka; Yuji Toiyama; Yoshinaga Okugawa; Tadanobu Shimura; Junichiro Hiro; Keiichi Uchida; Yasuhiko Mohri; Masato Kusunoki
Journal:  Med Oncol       Date:  2013-06-08       Impact factor: 3.064

3.  DUSP10 regulates intestinal epithelial cell growth and colorectal tumorigenesis.

Authors:  C W Png; M Weerasooriya; J Guo; S J James; H M Poh; M Osato; R A Flavell; C Dong; H Yang; Y Zhang
Journal:  Oncogene       Date:  2015-03-16       Impact factor: 9.867

Review 4.  Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance.

Authors:  Zahra Zandi; Bahareh Kashani; Zivar Alishahi; Atieh Pourbagheri-Sigaroodi; Fatemeh Esmaeili; Seyed H Ghaffari; Davood Bashash; Majid Momeny
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-04       Impact factor: 4.553

5.  Identifying the tumor location-associated candidate genes in development of new drugs for colorectal cancer using machine-learning-based approach.

Authors:  Tuncay Bayrak; Zafer Çetin; E İlker Saygılı; Hasan Ogul
Journal:  Med Biol Eng Comput       Date:  2022-08-10       Impact factor: 3.079

6.  Low DUSP4 Expression Is Associated With Aggressive Phenotypes and Poor Prognosis in Gastric Cancer.

Authors:  Seung Sam Paik; Seongsik Bang; Seungyun Jee; Hyunsung Kim; Kiseok Jang; Hosub Park; Jae Kyung Myung; Dongho Choi; Su-Jin Shin
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 7.  MicroRNAs as the critical regulators of Doxorubicin resistance in breast tumor cells.

Authors:  Amir Sadra Zangouei; Maliheh Alimardani; Meysam Moghbeli
Journal:  Cancer Cell Int       Date:  2021-04-15       Impact factor: 5.722

8.  miR‑122‑5p suppresses the oncogenesis of PTC by inhibiting DUSP4 expression.

Authors:  Ning Hu; Yanhua Tian; Yanmei Song; Leilei Zang
Journal:  Mol Med Rep       Date:  2021-03-24       Impact factor: 2.952

9.  The roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanisms.

Authors:  Khanh Vinh Quốc Lu'o'ng; Lan Thi Hoàng Nguyễn
Journal:  Cancer Manag Res       Date:  2012-12-18       Impact factor: 3.989

10.  A colorectal cancer genome-wide association study in a Spanish cohort identifies two variants associated with colorectal cancer risk at 1p33 and 8p12.

Authors:  Ceres Fernandez-Rozadilla; Jean-Baptiste Cazier; Ian P Tomlinson; Luis G Carvajal-Carmona; Claire Palles; María J Lamas; Montserrat Baiget; Luis A López-Fernández; Alejandro Brea-Fernández; Anna Abulí; Luis Bujanda; Juan Clofent; Dolors Gonzalez; Rosa Xicola; Montserrat Andreu; Xavier Bessa; Rodrigo Jover; Xavier Llor; Víctor Moreno; Antoni Castells; Ángel Carracedo; Sergi Castellvi-Bel; Clara Ruiz-Ponte
Journal:  BMC Genomics       Date:  2013-01-26       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.